Toll-Free 1-866-625-9854

Laxoya (Sennosides, Sodium Docusate)

Active Ingredient: Sennosides, Sodium Docusate
Dosage: 8.60/50 mg
Route of Administration: Oral
Dosage Form: Tablets
Quantity per package: 20 pills
Availability: Out of stock

Laxoya contains Sennosides, Sodium Docusate. This drug is prescribed for the treatment of occasional constipation. These pills will help to soften your stool.

Laxoya is no longer available for sale but you can find a good alternative for treating constipation on the website.


Stimulant laxative Laxoya tablets are indicated for the treatment of functional constipation, whether as a result of a persistent habit pattern, treatment with drugs that cause constipation, surgery or when associated with aging. In patients prone to impaction, these tablets may be useful in softening dry stools, while stimulating peristalsis gently. After surgery, the tablets help counteract intestinal inertia and hard stools resulting from inactivity, restricted fluid intake and diet. Its use is indicated in patients with cardiovascular disease, where effort should be avoided; in constipation associated with hemorrhoids and for the prevention and treatment of drug-induced constipation, including constipation associated with opioid therapy.

Dosage and administration

Laxoya is administered orally. It is recommended to take the tablets at bedtime. Recommended dosage: Adults and children 12 years or older: Initial dose: 2 tablets once a day. Maximum dose: 4 tablets twice a day. Children over 6 years: Initial dose: 1 tablet once a day. Maximum dose: 1 tablet twice a day.


  • Hypersensitivity;
  • Abdominal pain;
  • Nausea or vomiting of unknown nature;
  • Appendicitis (or presumable symptoms);
  • Intestinal obstruction and stenosis, intestinal atony;
  • Organic inflammatory colopathies (ulcerative rectocolitis, Crohn’s disease);
  • Undiagnosed rectal hemorrhage;
  • Metabolic water and electrolyte disorders;
  • Children under 12.

Side effects

Laxoya rarely causes side effects. Four patients treated with Laxoya reported headache, abdominal pressure, flatulence and intestinal cramps. A cause and effect relationship has not been established. Prolonged use or overdose with this laxative drug can cause diarrhea, resulting in excessive water loss and possibly an electrolyte imbalance. Prolonged use of these products can also cause atonic colon. Prolonged use of this preparation can cause reversible pigmentation of the colon, colonic melanosis. There were rare cases of finger spatulation, intermittent urinary excretion of aspartylglucosamine, hypogammaglobulinemia, hepatitis, tetanus and hypertrophic osteopathy associated with the excessive use of this product. A cause and effect relationship has not been established. Excessive or prolonged use of this laxative has been associated with rare cases of edema, amenorrhea, increased urinary concentrations of aldosterone, increased plasma renin activity, liver injury, leukopenia and hypomagnesemia. There have been rare reports of skin rashes, throat irritation, bitter taste, fatigue, weakness, thirst, hypoalbuminemia and bone pain, associated with the ingestion of preparations containing sodium docusate. A cause and effect relationship has not been established.

See also  Paramix (Nitazoxanide)


In case of accidental overdose, medical help is required. The typical symptomatology of an overdose of laxatives includes abdominal pain, weakness, fatigue, thirst, vomiting, hydroelectrolyte imbalance and discomfort that resemble colitis. It is recommended to rehydrate the patient via I.V.


No studies of pharmacological interactions with Laxoya tablets have been performed. However, docusate, one of the active ingredients in these tablets, can facilitate the absorption of mineral oil, thereby increasing its toxicity.